em-patch, page-5

annanaum i suggest you do some research as it appears your going off your assumptions.

http://www.fusioninvesting.com/2009/10/biota-holdings-relenza-royalties-tops-estimates/

http://www.wikinvest.com/stock/Avant_Immunotherapeutics_(AVAN)/Glaxosmithkline%20Plc%20Paul%20Royalty%20Fund

http://www.gsk.com/media/pressreleases/2010/2010_pressrelease_10131.htm

http://www.gsk.com/media/pressreleases/2007/2007_02_08_GSK969.htm

5-10% of gross revenue sounds bang on if not conservative...